Comparison of sulfinpyrazone and BL-3459 with S - 20344, a potent new antithrombotic agent.
D000818:Animals; D005343:Fibrinolytic Agents; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D008297:Male; D010080:Oxazoles / Q000494:pharmacology*; D010974:Platelet Aggregation / Q000187:drug effects; D011458:Prostaglandins E / Q000494:pharmacology; D011799:Quinazolines / Q000494:pharmacology*; D051381:Rats; D013442:Sulfinpyrazone / Q000494:pharmacology*; D013927:Thrombosis / Q000209:etiology
D005343:Fibrinolytic Agents; D007093:Imidazoles; D010080:Oxazoles; D011458:Prostaglandins E; D011799:Quinazolines; C009709:6-methyl-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-2-one hydrochloride; C031445:4-(4-bromophenyl)-2-methyl-5-nitrooxazole; D013442:Sulfinpyrazone